Synthesis and structure-activity relationships of novel 9-oxime acylides with improved bactericidal activity

Bioorganic & Medicinal Chemistry
Xu HanJian-Hua Liang

Abstract

9-Oxime acylides have different SAR and binding modes from 9-oxime ketolides. An aminopyridyl or carbamoylpyridyl group anchored at the end of the 9-oxime 2-propargyl group is beneficial for antimicrobial activity. Both the 2-pyridyl and 3-pyridyl groups derived from 3-OH have stacking interactions with the base pair G2505/C2610 (Escherichia coli numbering) of the bacterial rRNA. Compounds 3 presented characteristic features that belong to bactericidal agents when used against constitutive-erm resistant Staphylococcus aureus, susceptible and mef-encoded Streptococcus pneumoniae, inducible-erm resistant Streptococcus pyogenes, and Moraxella catarrhalis. A docking model indicated that the carbamoylpyridyl group of 3h may hydrogen bond to G2061 in addition to π-π stacking over the adenine of A2062 that proved to gate the tunnel for the egress of the nascent peptide. This study suggests that the 9-oxime acylides possess a bactericidal mechanism that is different from the traditional near-complete inhibition of protein synthesis. These studies provide a foundation for the rational design of macrolide antibiotics.

References

Jun 13, 2003·Journal of Medicinal Chemistry·Tetsuya TanikawaAtsushi Nishida
Dec 24, 2004·Antimicrobial Agents and Chemotherapy·Darren AbbanatKaren Bush
Nov 18, 2005·Bioorganic & Medicinal Chemistry Letters·Bin ZhuMark J Macielag
Dec 19, 2007·Antimicrobial Agents and Chemotherapy·Marne BaileyAlexander S Mankin
Feb 24, 2010·Antimicrobial Agents and Chemotherapy·Leah N WoosleyRonald N Jones
May 25, 2010·International Journal of Antimicrobial Agents·Manisha PandyaPradip Kumar Bhatnagar
Jul 22, 2010·Expert Opinion on Therapeutic Patents·Herbert A Kirst
Sep 22, 2010·Antimicrobial Agents and Chemotherapy·Beatriz Llano-SoteloAlexander S Mankin
Sep 30, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jack A DunkleJamie H D Cate
Sep 30, 2010·Proceedings of the National Academy of Sciences of the United States of America·David BulkleyThomas A Steitz
Nov 19, 2010·Bioorganic & Medicinal Chemistry Letters·David Pereira, Prabhavathi Fernandes
Apr 23, 2011·The Journal of Antimicrobial Chemotherapy·Takafumi SatoNaomasa Gotoh
Oct 30, 2012·Cell·Krishna KannanAlexander S Mankin
Dec 4, 2012·European Journal of Medicinal Chemistry·Jian-Hua LiangYing-Chun Xu
Feb 19, 2013·Bioorganic & Medicinal Chemistry Letters·Thomas V MageeVeerabahu Shanmugasundaram
Nov 6, 2013·Antimicrobial Agents and Chemotherapy·Marios G KrokidisGeorge P Dinos
Nov 19, 2013·Molecular Cell·Pulkit GuptaNora Vázquez-Laslop
Aug 27, 2014·Expert Opinion on Investigational Drugs·Nafsika H Georgopapadakou
Oct 29, 2014·Proceedings of the National Academy of Sciences of the United States of America·Krishna KannanAlexander S Mankin

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.